Literature DB >> 10857747

Alterations of H19 imprinting and IGF2 replication timing are infrequent in Beckwith-Wiedemann syndrome.

J A Squire1, M Li, S Perlikowski, Y L Fei, J Bayani, Z M Zhang, R Weksberg.   

Abstract

Beckwith-Wiedemann syndrome (BWS) is an overgrowth disorder resulting from dysregulation of multiple imprinted genes through a variety of distinct mechanisms. A frequent alteration in BWS involves changes in the imprinting status of the coordinately regulated IGF2 and H19 genes on 11p15. Patients have been categorized according to alterations in the imprinted expression, allele-specific methylation, and regional replication timing of these genes. In this work, IGF2/H19 expression, H19 DNA methylation, and IGF2 regional replication timing were studied in nine karyotypically normal BWS fibroblasts and two BWS patients with maternally inherited 11p15 chromosomal rearrangements. Informative patients (9/9) maintained normal monoallelic H19 expression/methylation, despite biallelic IGF2 expression in 6/9. Replication timing studies revealed no changes in the pattern of asynchronous replication timing for both a patient with biallelic IGF2 expression and a patient carrying an 11p15 inversion. In contrast, a patient with a chromosome 11;22 translocation and normal H19 expression/methylation exhibited partial loss of asynchrony and a shift toward earlier replication times. These results indicate that in BWS, (1) H19 imprinting alterations are less frequent than previously estimated, (2) IGF2 imprinting and H19 imprinting are not necessarily coordinated, and (3) alterations in regional replication timing are generally not correlated with either chromosomal rearrangements or the imprinting status of IGF2 and H19.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10857747     DOI: 10.1006/geno.2000.6155

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  4 in total

1.  Maternal gametic transmission of translocations or inversions of human chromosome 11p15.5 results in regional DNA hypermethylation and downregulation of CDKN1C expression.

Authors:  Adam C Smith; Masako Suzuki; Reid Thompson; Sanaa Choufani; Michael J Higgins; Idy W Chiu; Jeremy A Squire; John M Greally; Rosanna Weksberg
Journal:  Genomics       Date:  2011-11-03       Impact factor: 5.736

2.  Epigenotype-phenotype correlations in Beckwith-Wiedemann syndrome.

Authors:  J R Engel; A Smallwood; A Harper; M J Higgins; M Oshimura; W Reik; P N Schofield; E R Maher
Journal:  J Med Genet       Date:  2000-12       Impact factor: 6.318

3.  Constitutional and somatic methylation status of DMRH19 and KvDMR in Wilms tumor patients.

Authors:  Leila C A Cardoso; Jair A Tenorio Castaño; Hanna S Pereira; Maria Angélica de F D Lima; Anna Cláudia E Dos Santos; Paulo S de Faria; Sima Ferman; Héctor N Seuánez; Julián B Nevado; José Carlos Cabral de Almeida; Pablo Lapunzina; Fernando R Vargas
Journal:  Genet Mol Biol       Date:  2012-11-09       Impact factor: 1.771

4.  Misbehaviour of XIST RNA in breast cancer cells.

Authors:  Silvia M Sirchia; Silvia Tabano; Laura Monti; Maria P Recalcati; Manuela Gariboldi; Francesca R Grati; Giovanni Porta; Palma Finelli; Paolo Radice; Monica Miozzo
Journal:  PLoS One       Date:  2009-05-15       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.